HLA-C and neoplasm: Tumor cells with DDR deficiency tend to have a high TMB, which is believed to be a key driver in the generation of immunogenic neoantigens displayed on the major histocompatibility complexes (MHC) on the tumor cell surface that influence patient response to immunotherapy.7, 12